TOFACITINIB CITRATE (TOFACITINIB CITRATE) — FDA Approval ANDA216001 (SINOTHERAPEUTICS INC)
TOFACITINIB CITRATE (TOFACITINIB CITRATE) — FDA Approval ANDA216001 (SINOTHERAPEUTICS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TOFACITINIB CITRATE; Active ingredients: TOFACITINIB CITRATE; Application number: ANDA216001.
| Brand name | TOFACITINIB CITRATE |
|---|---|
| Active ingredients | TOFACITINIB CITRATE |
| Application number | ANDA216001 |
| Sponsor | SINOTHERAPEUTICS INC |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20250930 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →